FDA
-
-
-
-
-
-
-
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
-
-
-
-
-
-
-
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
-
-
-
-
-
-
-
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
-
-
-
-
-
-
-
Lab Corp. (LH) Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
-
-
-
-
-
-
-
Qiagen (QGEN) Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies
-
-
-
-
-
-
-
QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021
-
-
-
-
-
-
-
Qiagen (QGEN) to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

